An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients

Clinical trial NCT02332811 · COMPLETED

Trial details

NCT number: NCT02332811
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Renal Failure Chronic

Start date: 2013-10-01
Primary completion: 2014-07-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.